Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Rockwell Medical Inc (RMTI) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
USANA Health Sciences Inc (USNA) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
Mexico Pharmaceuticals & Healthcare Q3 2019
... for innovativedrugmakers, while generic drug sales will continue to outperform. The government goal to expand access to healthcare services willsupport rising health expenditure. Government efforts to centralise drug purchasing and distribution pose increased risks of ... Read More
-
Kenya Pharmaceuticals & Healthcare Q3 2019
... boosted factors such as the risingpopulation numbers, which recently surpassed 50 million, the pending rollout of universal health coverage, high technologicalliteracy of its people and the prevalent disease profile. However, the lacking healthcare financing and ... Read More
-
Lebanon Pharmaceuticals & Healthcare Q3 2019
... long-term opportunities fordrugmakers on the back of expanding healthcare access and an evolving epidemiological and demographic profile. High localproduction costs and weak infrastructure remain major obstacles for drugmakers setting up manufacturing operations in themarket. Despite ... Read More
-
Sri Lanka Pharmaceuticals & Healthcare Q3 2019
... thatbroader segments of the population have improved access to healthcare. Despite rising demand for medicine, the market willremain challenging for innovative pharmaceutical companies. Drug price controls and rising localisation of drug production poserisks to drugmakers, ... Read More
-
Puerto Rico Pharmaceuticals & Healthcare Q3 2019
... to support the development of Puerto Rico's healthcare and pharmaceutical markets. However, we expect the territoryto struggle to provide major commercial opportunities, in the face of lacking federal funding and the need for fiscal austerity. Read More
-
Norway Pharmaceuticals & Healthcare Q3 2019
... support progress in several areas,including R&D and pharmaceutical sector developments. Despite high per capita expenditure on healthcare, comparatively lowdrug prices and slow uptake of newly approved medicines will continue to weigh on the market potential. Read More
-
Hong Kong Pharmaceuticals & Healthcare Q3 2019
... inwhich the expenditure on public healthcare services increased to a larger proportion of total recurrent expenditure. While theHospital Authority continues to receive the lion's share of resources, other areas such as healthcare manpower, training, andpromotion ... Read More
-
Vietnam Pharmaceuticals & Healthcare Q3 2019
... investment are just some of the factors that would provide a fertile ground for substantialvolume and value growth. However, this potential will mostly attract generic drug companies, given the low pharmaceuticalspending and regulatory regime risks. Read More
-
Growth Insights on the US In vitro Fertilization Services Market, 2018
... services for help. 1 in 8 couples in the United States experience pregnancy-related difficulties that fertility treatments can address. Key market drivers include the increasing rate of obesity causing deterred ovulation in women and low ... Read More
-
Cuba Pharmaceuticals & Healthcare Q3 2019
... as the main factorsdriving medicine sales. However, increasing US sanctions on Cuba, a poor intellectual property environment and a relativelycompetitive domestic industry make Cuba a highly challenging market with few opportunities for multinational drugmakers. Cubawill ... Read More
-
Germany Pharmaceuticals & Healthcare Q3 2019
... continue tosupport this potential. However, we do caution that market access is now challenging, as authorities use a range of cost-containment measures and downward price pressures as a means of controlling state spending on medicines. Read More
-
Iraq Pharmaceuticals & Healthcare Q3 2019
... benefiting health sectorperformance. That said, infrastructure bottlenecks and high country and industry risks will remain major challenges in the shortterm, limiting drugmaker opportunities. Ongoing government efforts to streamline public procurement of medicines will contributetowards gradually ... Read More
-
Ireland Pharmaceuticals & Healthcare Q3 2019
... multi-year health sectorreform, will support this trend. However, the market attractiveness to innovative drugmakers will remain subdued due to the slowuptake of new medicines and persistent cost-control measures targeting drug spending. Meanwhile, Ireland’s export-ledpharmaceutical manufacturing ... Read More
-
Kyrgyzstan Pharmaceuticals & Healthcare Q3 2019
... unified medicine registration system in the Eurasian Economic Unionwill support access to medicines; however, major barriers - such as the prevalence of counterfeit medicines and challenges in supplyand distribution across the country - will remain. Read More
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast
... Global Forecast to 2024 The study involved four major activities in estimating the current size of the leukemia therapeutics market. Exhaustive secondary research was done to collect information on the market and its subsegments. The ... Read More
-
Health Supplement Stores
... based in the US), along with Holland & Barrett (UK). COMPETITIVE LANDSCAPE Health and nutrition trends, aging populations, and consumer spending drive demand. The profitability of individual companies depends on product innovation, effective merchandising, and ... Read More
-
Cephalosporin Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025
... The report predicts the global cephalosporin drugs market to grow with a CAGR of 3.5% over the forecast period from 2019-2025. The study on cephalosporin drugs market covers the analysis of the leading geographies such ... Read More
-
Contract Research Organizations Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025
... to 2025. The report predicts the global contract research organizations market to grow with a CAGR of 6.35% over the forecast period from 2019-2025. The study on contract research organizations market covers the analysis of ... Read More
-
Bio-pharmaceutical Logistics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025
... The report predicts the global bio-pharmaceutical logistics market to grow with a CAGR of 7.8% over the forecast period from 2019-2025. The study on bio-pharmaceutical logistics market covers the analysis of the leading geographies such ... Read More
-
Bleeding Disorders Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025
... to 2025. The report predicts the global bleeding disorders treatment market to grow with a CAGR of 7.8% over the forecast period from 2019-2025. The study on bleeding disorders treatment market covers the analysis of ... Read More
